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1571 ABSTRACT 
Non-invasive measuring devices responsive to changes in a 
patient’s intracranial pressure (ICP) can be accurately cali- 
brated for monitoring purposes by providing known changes 
in ICP by non-invasive methods, such as placing the patient 
on a tilting bed and calculating a change in ICP from the tilt 
angle and the length of the patient’s cerebrospinal column, 
or by placing a pressurized skull cap on the patient and 
measuring the inflation pressure. Absolute values for the 
patient’s pressure-volume index (PVI) and the steady state 
ICP can then be determined by inducing two known changes 
in the volume of cerebrospinal fluid while recording the 
corresponding changes in ICP by means of the calibrated 
measuring device. The two pairs of data for pressure change 
and volume change are entered into an equation developed 
from an equation describing the relationship between ICP 
3,830,233 8/1974 Hill ........................................... 128/71 and cerebrospinal fluid volume. PVI and steady state ICP are 
4,003,141 1/1977 Leroy .................................. 128/748 X then determined by solving the equation. Methods for induc- 
4,080,653 3/1978 Barnes, Jr. et d. ................ 128/748 X 
4,114,606 9/1978 SeylX ................................. 128/748 x described. 
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NON-INVASIVE METHOD AND APPARATUS 
FOR MONITORING INTRACRANIAL 
PRESSURE AND PRESSURE VOLUME 
INDEX IN HUMANS 
ORIGIN OF THE INVENTION 
The invention described herein was made in the perfor- 
mance of work done by employees of the U.S. Government 
and may be manufactured and used by or for the government 
for governmental purposes without the payment of any 
royalties thereon or therefor. 
This is a continuation-in-part of application Ser. No. 
081297,474 filed on Aug. 25, 1994 abandoned. 
BACKGROUND OF THE INVENTION 
1. Field of The invention 
This invention relates in general to measuring/monitoring 
of intracranial pressure and pressure volume index in human 
patients, and more specifically to a non-invasive method for 
monitoring intracranial pressure and changes in intracranial 
pressure. 
2. Description of the related art 
Monitoring of intracranial pressure and pressure volume 
index is of significant diagnostic and post-operative impor- 
tance for patients with cranial injuries, pathologies, or other 
conditions, that may affect the pressure of the subarachnoi- 
dal fluid around the brain, and for patients who have 
undergone brain surgery. 
Intracranial pressure is regularly measured and monitored 
by means of a pressure sensor inserted through the skull into 
the brain. Usually a hole is drilled in the skull, and a catheter 
with a pressure sensor is inserted into the brain fluid. To 
obtain a pressure volume index, the change in intracranial 
pressure is monitored after a known bolus of saline solution 
is inserted into the cerebrospinal fluid, or after a saline 
solution is inserted at a known rate. This known procedure, 
while simple and accurate, is not suitable for long term 
monitoring, because an open wound must be maintained in 
the skull for the catheter with the pressure sensor. Antibiotics 
are only partially effective in treating cranial infections, so 
the pressure sensor can only be left in situ for two weeks or 
less. 
Long term monitoring of intracranial pressure, without 
the need for maintaining an open wound in the skull, is 
possible if a pressure sensor with a transmitter is implanted 
into the brain. The intracranial pressure is thereafter moni- 
tored by means of a receiver located outside the skull. Such 
a solution however, is unattractive because of risks involved 
in implanting anything in the brain, and because of the 
problems of providing power to an implanted transmitter. 
One such remote pressure sensor is described in U.S. Pat. 
No. 4,124,023 to Fleischmann et al. However, this device 
uses nuclear material as an energy source, making it poorly 
suited for implantation into a human brain. 
Other methods, claiming to be non-invasive methods 
suitable for monitoring of intracranial pressure, are based on 
the measurement of some quantity that depends on intrac- 
ranial pressure, but which does not have a fixed relationship 
to intracranial pressure. 
One such method is described in U.S. Pat. No. 4,204,547 
to Allocca. Allocca occludes the blood flow in a jugular vein 
for a few seconds, and measures the resulting rate of change 
of blood flow within the jugular vein upstream of the 
occlusion as an indicator of the intracranial pressure. 
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Another such method, proposed in U.S. Pat. No. 4,564, 
022 to Bosenfeld et al., directs a sensory stimulus towards 
the patient, e.g. a flash of light into the eyes, and measures 
the latency of a resulting negative-going wave of electrical 
brain activity as an indicator of intracranial pressure. 
These known indirect methods may be used, under very 
restricted conditions, as possible indicators of variations of 
the intracranial pressure in a patient. However, absolute 
values for the intracranial pressure cannot be obtained 
directly as there is no predetermined fixed ratio between the 
observed signals, obtained by these known non-invasive 
monitoring methods, and the absolute value of the intracra- 
nial pressure. Such calibration is possible by inserting a 
pressure sensor into the brain of the patient being monitored, 
however, this is a traumatic and undesirable procedure. 
SUMMARY OF THE INVENTION 
Accordingly, it is the object of the present invention to 
provide a non-invasive method for measurement of absolute 
values of intracranial pressure and pressure volume index in 
a human patient. 
It is another object of the present invention to provide a 
non-invasive method for long term monitoring of both 
intracranial pressure and the pressure volume index in a 
human patient. 
It is a further object of the present invention to provide a 
non-invasive method for calibrating indirect measurements 
of intracranial pressure to obtain absolute values for intrac- 
ranial pressure. 
It is a still further object of this invention to provide a 
means to monitor changes in intracranial pressure in a 
human patient. 
These and other objects of the invention are achieved by 
a method for non-invasive measurement of intracranial 
pressure and pressure volume index, which comprises the 
steps of: providing a non-invasive measuring device respon- 
sive to intracranial pressure, calibrating said measuring 
device by introducing known changes in intracranial pres- 
sure and recording the pressure changes by the measuring 
device, inducing known changes in the volume of the 
cerebrospinal fluid while measuring the corresponding 
changes in intracranial pressure by means of said calibrated 
measuring device, obtaining two sets of corresponding val- 
ues for change in volume (AV) and change in intracranial 
pressure (Ap), entering each of the two sets of values for AV 
and Ap into equation 
AV - 
AP=Po(lO - 1) 
to form a set of two equations with Po and PVI unknown, 
and solving said set of two equations for PVI and Po to 
obtain accurate values for the pressure volume index PVI 
and the intracranial pressure Po for the patient. 
BRIEF DESCRIPTION OF THE DRAWINGS 
These and other objects of the present invention will he 
understood from the description herein, with reference to the 
accompanying drawings, in which: 
FIG. 1A is a side view of a patient with sensing devices 
attached to forehead and neck lying in supine position on a 
horizontal hospital bed; 
FIG. 1B is a side view of a patient with sensing devices 
attached to forehead and neck lying in supine position on a 
tilted hospital bed; 
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FIG. 2 is a perspective view of a seated patient with a 
sensing device attached to the forehead and fitted with a 
pressurized skull cap; 
device attached to the forehead lying on the side; 
be calculated by solving the simultaneous equations (3a) and 
(3b) by known methods. Examples of methods for solving 
this set of equations are given below. 
FIG. 3 is a perspective view of a patient with a sensing BY taking the ratio of equations (3a) and (3b), equation (4) 
5 is obtained: 
FIG. 4 is a block diagram of a preferred measuring device -- mi 1oAVi/PVI - 1 (4) 
DETAILED DESCRIPTION OF A PREFERRED A quite accurate value for PVI is obtained by inserting 
EMBODIMENT 10 into equation (4) data from the measurement of two pairs of 
corresponding values for AV and Ap and fitting a computer 
The human brain and the spinal cord are immersed in a generated algorithm of equation (4) to the data by varying 
fluid called the cerebrospinal fluid. The cerebrospinal fluid PVI, or by using the “SOLVE’ function in modem scientific 
(cso is continuously generated and reabsorbed by the body. calculators. 
The csf is contained in a membrane covering the inside of 15 An approximate, but quite accurate, value for PVI may 
the skull and the spinal cord, having a sack at the sacrum. also be obtained by expanding the exponential functions in 
n e  brain and the membrane containing the csf also contain the numerator and the denominator of the right hand side of 
blood vessels, which are in direct communication with the equation (4) in a truncated power series, collecting terns, 
csf and add to the total volume of the cerebrospinal system. and solving the resulting equation for PVI. If the first three 
The blood volume varies rhythmically with the heart beat, 2o krms in the power series is kept, equation (5) for PVI is 
causing corresponding oscillations in the intracranial pres- Obtained 
MI (5)  sure (ICP). An accurate regulating process in the brain 
A P 2  normally controls the generation process, the reabsorption 
constant ICP average value of about 40 mHK However, the 25 
regulating process can be disturbed, e.g. by tumors in the 
brain, or by trauma to the brain, causing the ICP change. As 
little as 10 mm, increase above average value in the ICp 
may cause insidious damage to the brain. 
varies. As an example a relationship between volume and 
ICP is expressed by equation (1) for the cerebrospinal 
system for small values of (V-V,). 
for use with the invention. A?’2 - 1oAV2/PVl- 1 
(Ah)’  - (Avi)’ - 
process and the blood volume in the brain to maintain a PVI = 
0.868 AV1 -- AV2 c 2 1 
If the first four terms in the power series is kept, the more 
accurate, but Still approximate, equation (6) for PVI is 
obtained: 
PVI=A/B (6a) When the ICP varies, the total volume of the csf also 30 
Where: 
Apl  (6b) 
A = 4.61 [ ( A W 3  - (AVI)~  ] 
35 
v-vo 
and: P = P o X l O  PV’ 
where: 
P=peak ICP 
V=csf volume associated with P 
40 MI Ap1 
APz A p 2  
24 - (AVZ)~(AVI) - 18 - (AV# - (AVz)’ - P,=Steady state reference pressure for JCP 
V,=Steady state reference volume of csf corresponding to 
PVI=Pressure-Volume Index 
PVI is a constant that depends on pathological conditions 45 
IR 
PO 
15 ( 2  -1 (Avz)4- 15 (Av1)4] 
of a given patient and varies from patient to patient, such that 
no fixed or predetermined value for PVI can be used in 
equation (1). An accurate value for PVI can, however, be 
calculated from known values for changes in ICP (Ap) and 
volume (AV) as follows: 
Subtracting Po from each side of equation (1) gives 
Once PVI is obtained, Po can be calculated from either of 
equations (3a) or (3b) by inserting the correct value for PVI. 
Another way to calculate Po from a single measured pair 
of AP and AV when PVI has been determined may also be 
5o obtained by taking the derivative of equation (1) to get 
equation (7): 
equation (2): 
(2) 55 
AP=P,(lPP”’l-) 
where 
AV=V-V,=small variation in volume from V, 
AP=P-P,=small variation in pressure from Po 
If two pairs of AV and AP are measured, equations (3a) 
and (3b) are obtained: 
APp,=Po(l @V”P”‘-l) ( 3 4  
AP*=P,( l P V ~ P ” ’ - l )  (3b) 
Equations (3a) and (3b) are a set of two equations with 
only two unknown variables, PVI and Po, so PVI and Po can 
65 
AV dP Po - ~- 
dV - 0.434(PVJ) lo “I 
(7) 
For small variations in P and V, dP and dV can be replaced 
by Ap and AV, respectively, and the resulting equation 
solved to get an approximate, but quite accurate equation (8) 
for Po: 
-AV 
Po = 0.434(PVZ) E loy AV 
Measurements of AP and AV can be obtained by non- 
invasive methods. Two preferred methods, but by no means 
the only methods, to measure AP and AV for the determi- 
nation of intracranial pressure and pressure-volume index 
will be described below. 
It is commonly assumed that the skull of an adult is so 
rigid that the skull volume is constant. It is therefore 
5,61 
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assumed that changes in csf volume (AV) involve mainly 
compression of the spongy brain tissue. Comprehensive 
tests have shown that this assumption is incorrect. The skulls 
of adults actually expand and contract like balloons with 
changes in ICP, and this expansion and contraction of the 
skull accounts for almost all of the volume changes in the csf 
caused by variations in the ICP. 
Any measurement system or device sufficiently sensitive 
to respond to appropriate anatomical configuration changes 
caused by pressure changes can accordingly be used to 
measure changes in ICP. A preferred device for measuring 
small variations in skull size in response to variations in ICP 
is the constant frequency pulsed phase-locked-loop (CFP- 
PLL) ultrasonic measurement device described by U.S. Pat. 
No. 5,214,955 issued to Yost and Cantrell, and also 
described in a paper entitled “Constant frequency pulsed 
phase-locked-loop instrument for measurement of ultrasonic 
velocity” by Yost, Cantrell and Kushnick, published in Rev. 
Sci. Instrum. 62 (10) October 1991. The CFPPLL measure- 
ment device applied to measuring or monitoring intracranial 
pressure will be described below with reference to FIG. 4. 
The signal from the ultrasonic CFPPLL device depends 
on the diameter of the cranium and is not a direct measure 
of the intracranial pressure ICP. This is true for all measure- 
ment devices based on mechanical deformation of the skull 
or related structures, as well as all other known non-invasive 
measurement devices responsive to intracranial pressure 
variations. The signal from such non-invasive measurement 
devices thus can not be used for measurements or monitor- 
ing of absolute ICP variations unless a calibration as will be 
described herein has first been performed. 
A. Methods to measure AI? 
1. Tilt angle method. 
FIGS. 1A and 1B show a patient 10 lying supine on a 
hospital bed 40. An ultrasonic transducer 20 mounted on the 
front of the skull above the nose and approximately 1 cm 
below the hairline is connected via a cable 22 to an elec- 
tronic apparatus 30. The measuring device 20,30 provides 
an output proportional to changes in the travel time of an 
ultrasonic toneburst emitted by the transducer 20 and 
reflected back to the transducer 20 from the opposite side of 
the skull 12 or other appropriate landmark L. 
In FIG. 1A the bed 40 is horizontal, and in FIG. 1B the 
bed 40 is tilted by an angle $ from the horizontal 26, such 
that the patient’s legs 19 are higher than the head 12. The 
cerebrospinal fluid is contained in membranes extending 
from the inside of the top of the skull 12 to the sacrum, 
which lies approximately at “S” in FIGS. 1A and 1B. When 
the bed 40 is tilted as shown, the intracranial pressure will 
increase. Measuring device 20,30 provides a measurement 
of a change in skull 12 dimension in response to a change in 
intracranial pressure. If the distance from the center of the 
skull 12 to the sacrum is L, as indicated in FIGS. 1A and 1 
B, the increase in pressure will be as given in equation (9): 
AP=pg L sin $I 19) 
where: 
AP=Pressure change 
p=Mass density of the spinal fluid 
g=Gravitational constant 
L=Distance 
$=Tilt angle for patient 
By using various tilt angles 9, the various changes in 
intracranial pressure (ICP) can be calculated from equation 
(9). These calculated changes in ICP can be used to calibrate 
the output from the measuring device 30, or any other 
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appropriate measuring device sufficiently sensitive to 
respond to appropriate anatomical configuration changes 
caused by changes in intracranial pressure. 
2. Pressurized skull cap method. 
FIG. 2 illustrates another method of calibration, which 
uses a helmet 40 containing an inflatable skull cap 45, in 
which a known pressure is applied to the cranial vault 12 by 
means of a hose 57, a pump 50, a valve 55, and a manometer 
60. Calibration is accomplished by correlating the output of 
a measuring device with a transducer 20 mounted on the 
front of the skull 12 with the applied pressure in the skull cap 
45. The accuracy of this method depends on the refinements 
of the design of the skull cap 45 and may differ from the 
accuracy of the tilt-angle method outlined above. 
B. Methods to vary and measure AV: 
1. Bolus Injection method. 
FIG. 3 shows a patient 10, whose cerebrospinal axis is in 
the supine position, but where the patient is rotated onto the 
patient’s side. The patient has an ultrasonic transducer 20 
placed against the skull directly above the nose and approxi- 
mately one centimeter below the hair line. This transducer 
20 is connected via cable 22 to an electronic apparatus 30 for 
measurement of small variations in the diameter of the skull 
12. 
Between appropriate vertebrae, or at an other appropriate 
access point, a measured bolus of saline or other appropriate 
solution is injected by a syringe 70 into the cerebrospinal 
system. Let the volume of a first injection be AVl. By 
assuming that the injection of this bolus is given at the 
clinically recommended and appropriate injection rate, it 
will give rise to a peak change in intracranial pressure AP,. 
This pressure change AP, is measured by readings from the 
measuring device 20, 30, which previously has been cali- 
brated by the tilt angle method or the pressurized skull cap 
method, and is recorded along with the corresponding bolus 
injection volume AVl. 
After allowing time for the intracranial pressure ICP to 
equilibrate to its steady state value following the first bolus 
injection, a second bolus injection of volume AV2 is given, 
and the resulting peak change in intracranial pressure Ap2 is 
measured. 
The two measured pairs of values of AV and Ap are then 
inserted into equations (3a) and (3b), and the patient’s 
pressure-volume index PVI and the intra-cranial pressure Po 
is calculated by solving the two simultaneous equations by 
one of the methods described above in connection with 
equations (4)-(8). 
2. Blood Flow Method: 
Another method for measurement of AV is based on 
measurement of changes in blood flow to the brain, as 
indicated in FIG. 1A. 
A patient 10 resting in supine position on a horizontal 
hospital bed has an ultrasonic transducer 20 placed against 
the front of the skull 12. The transducer 20 is connected via 
a cable 22 to an electronic apparatus 30 for accurate mea- 
surement of small variations in the diameter of the skull 12. 
The measuring device 20,30 has previously been calibrated 
by the tilt angle method or the pressurized skull cap method 
described above to provide accurate readings of variations in 
the intracranial pressure. 
The patient 10 also has an ultrasonic blood flow trans- 
ducer 25 mounted on the neck. The blood flow transducer 25 
is connected via a cable 27 to an blood flow meter 35. The 
blood flow transducer 25 with associated blood flow meter 
35 is arranged to measure the blood flow in the patient’s 
jugular vein. The diameter of the jugular vein can be 
determined by using an ultrasonic A-scan instrument. By 
5,617, 
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using the determined vein diameter together with the veloc- 
ity profile from the blood flow meter 35, an instantaneous 
blood volume change can be determined. Devices for mea- 
surement of blood flow and blood vessel diameter are well 
known in the art, and will not be discussed in detail herein. 5 
Theoretically, net blood flow into or out of the brain 
would require measurement of the blood flow in all veins as 
well as in all arteries that service blood flow out of and into 
the cerebral system. In most cases it is, however, possible to 
model the total blood flow from measurement of blood flow 10 
in one vein. With this in mind, we measure (1) the diameter 
of the vein, and (2) the velocity profile of the venous flow. 
We calculate a blood volume flow rate in a manner known 
to those skilled in the art. 
a temporary occlusion of an artery or a vein. One can then 
calculate a first change in blood volume AVl, which is 
recorded together with the corresponding change Ap, in ICP, 
as measured by the previously calibrated pressure respon- 
A second pair of data, AV2 and AP2, is obtained by 
occluding a different vein or artery. The two pairs of data are 
inserted into equations (3a) and (3b), and PVI and Po are 
then calculated by solving the two equations, e.g. as 
After the patient's pressure-volume index PVI and steady 
state intracranial pressure Po has been determined, the 
calibrated measuring device 20,30, or any other calibrated 
measurement device responsive to changes in intracranial 
pressure, can be used to monitor changes in ICP directly and 30 
continuously. 
FIG. 4 is a block diagram for a Constant Frequency 
Pulsed Phase-Locked-Loop (CFPPLL) ultrasonic measure- 
ment device, which is a preferred measurement device for 
The CFPPLL measurement system uses properties of an 
ultrasonic wave propagating along a path defined by the 
ultrasonic beam and bound by the skull-meninges-dura 
complex, or appropriate substructures within this complex, 
and the measured change in the phase of the propagating 40 
ultrasonic wave due to the change in the wave propagation 
path length accompanying a change in ICP is used as a 
measure of variations in ICP. The CFPPLL measuring 
device is preferred because it provides very high sensitivity 
The CFPPLL measuring device includes an ultrasonic 
transducer 20, which is shown mounted on the front of the 
skull 12 of a patient under monitoring. The transducer 20 is 
via cable 22 supplied with variable width acoustic tonebursts 
from an electronic apparatus 30, which includes a constant 50 
frequency synthesizer 100 followed by a power splitter 110, 
a gate 115, which determines the width of the acoustic 
toneburst, a power amplifier 120, and a coupling/decoupling 
network 125. 
is received by the transducer 20 and channelled via the cable 
22, the coupling/decoupling network 125, and a preamplifier 
130 to a first input (1) of a phase detector 140. A second 
input (2) of the phase detector 140 receives a second signal 
from the synthesizer 100 via a power splitter 110, a buffer 60 
112, a voltage controlled phase shift network 170, a cali- 
brated line stretcher 175, and another buffer 172. 
The output signal from the phase detector 140 is fed via 
a sample-and-hold circuit 150 to an integrator 155, and from 
the integrator 155 via a normally closed phase shift control 65 
switch 168 to an adder circuit 160, which also receives a 
phase set point voltage from a phase set point potentiometer 
The change in the blood volume flow rate is measured at 15 
sive measuring device 20, 30. 20 
described above with reference to equations (4)-(8). 25 
use as part of the invention. 35 
and excellent repeatability and long term stability. 45 
Acoustic signals reflected from the far side of the skull 12 55 
873 
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165. The output from the adder circuit 160 is fed as a control 
voltage to input 180 of the phase shift network 170, and also 
to a digital voltmeter 200 used :as readout for the measuring 
device. The digital voltmeter includes an BEE interface 
connection 210 for external data storage and processing. 
A timing control unit 190 provides all sync and control 
signals for the gate 115, the coupling/decoupling network 
125, and the sample-and-hold circuit 150. The couplingl 
decoupling network 125 protects the preamplifier 130 from 
overload by decoupling the preamplifier 130 from the trans- 
ducer 20 when large voltage drive signals are coupled to the 
transducer 20, and it improves system sensitivity by decou- 
pling the output of the low-impedance drive amplifier 120 
from the transducer 20 when a reflected signal is received by 
the transducer 20. 
The apparatus 30 also provides outputs for supervision 
and setup, including transducer output 133, phase compari- 
son output 143, control point monitor output 153, and sync 
signal output 193. 
The function of the CFPPLL system outlined above is best 
understood by considering that a constant frequency signal 
from an oscillator 100 is split into two signal paths, 1 and 2, 
and that phase differences between the two signal paths are 
measured. 
Along path 1, which is a measurement path, an acoustic 
signal generated in transducer 20 traverses the material 
enclosed by the skull 12 of the patient. The acoustic toneb- 
urst travels through the material enclosed by the skull 12, is 
reflected at the far end of the skull 12, and impinges on the 
transducer 20 as an echo of the original pulse. Any changes 
in the propagation conditions, such as path length changes, 
produce associated phase changes in path 1. These phase 
changes are the information sought in measurement. 
Path 2, which is a reference path, includes a voltage 
controlled phase shift network 170, whose output is used for 
phase comparison with the signal from the measurement 
path (1). The phase detector 140 detects the relative phase 
difference between the signals in the two paths, and gener- 
ates an output signal proportional to the cosine of the phase 
difference. The control voltage to the voltage controlled 
phase shift network 170 is automatically changed until the 
output voltage of the phase detector 140 is zero, which 
occurs when the two signals are in quadrature. 
The input to the voltage controlled phase shift network 
170 comes through a buffer 112 from the power splitter 110. 
The buffer 112 provides matching of the electrical input 
impedance to that of the phase shift network 170. The phase 
shift is controlled by a dc voltage applied to a control input 
181 of the voltage controlled phase shift network 170. The 
output of the voltage controlled phase shift network 170 
passes through a calibrated line stretcher 175, used for 
calibration of the system, and a buffer 172 to the phase 
detector 140. During data collection the setting of the 
calibrated line stretcher 175 is not changed. 
Phase comparison of the two paths is performed by the 
phase detector 140, which is a product detector combined 
with a low pass filter. The phase detector 140 output voltage 
can be written as one-half the product of the input voltage 
amplitudes times the cosine of the phase difference between 
' the two signals. The output of the phase detector 140 is 
passed both to the sample-and-hold circuit 150, which 
selects the desired portion of the phase signal, and to an 
output port 143 through a buffer 142 for observation on an 
oscilloscope (not shown). The portion of the phase signal 
chosen for measurement is selected by an adjustable timing 
pulse to the sample and hold circuit 150, whose output is 
passed to an integrator 155. 
5,617,873 
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The loop control circuit, which is made up of the sample- index PVI according to the present invention, such absolute 
and-hold 150, the integrator 155, the phase set point poten- calibration of output versus phase angle is not required, but 
tiometer 165, and the adder 160, provides the control voltage instead the change in output versus change in I c p  is Cali- 
180 for the voltage controlled phase shift network 170. The brated by the tilt angle method or the Pressurized Skull Cap 
control voltage 180 is a sum of two contributions, one 5 method as desCribed above. 
coming from the integrator 1 j j, and the other coming from The method described above for non-invasive determina- 
potentiometer 165 sets the nominal phase shift about which the invention is not only useful for direct monitoring of ICP, 
but also for calibration of other measuring devices using the system operates. The integrator 155 provides a voltage indirect methods for non-invasive monitoring of ICP. Such 
the phase set point potentiometer 165. The phase set point tion of PVI and Icp according to a preferred embodiment Of 
derived from the phase detector 140’ When the phase lo non-invasive measuring devices include, but are not limited 
detector 140 Output to, calipers, head bands, or other devices and measurement 
systems possessing the sensitivity and accuracy to allow 
the integrator 155 Output 
and quadrature to a 
between paths and are The phase shift proper calibration, for example, by using the measurement 
control switch 168 is closed in the “locked” state when the systems to monitor any dimensional changes in the skull or 
system is taking a measurement. For Setup, it is moved to its 15 other connected systems, such as the eyeball, inner ear, or 
shift network 170 is under manual control by the phase set cavity and/or the spine or attached or adjacent structures, or 
point potentiometer 165. configurational changes of the spine or any other structures 
The timing control unit 190 forms all of the necessary responding to increases in intracranial pressure. The inven- 
timing signals needed by various sections for the measure- 20 tion makes it possible to calibrate such devices so accurate 
ment application. All timing signals are referenced to the continuous recordings of absolute values of ICP can be 
repetition rate, which is determined by counting down from obtained without the need for invasive procedures. 
the synthesizer 100. The sync output marks the begiMing of N m m m ~ ~ s  n~~difications and adaptations of the Present 
the formation of a toneburst and is used for measurement invention will be apparent to those skilled in the art. Thus, 
setup and display, adjustable width of the toneburst is 25 the following claims and their equivalents are intended to 
open “unlocked” state, SO that the voltage controlled phase anatomical landmarks within or adjacent to the cranial 
also provided. Signals to the coupling/decoupling network cover all such modifications and adaptations which 
125 and the sample-and-hold circuit 150, used to measure within the m e  spirit and scope Of the present invention. 
What is claimed is: 
1. A method for non-invasive measurement of intracranial the phase of the selected portion of the received ultrasonic 
adjusted with the aid of an oscilloscope. 
Adjustments for measurements are made in the following 
(a) calibrating a measuring device by introducing known way: changes in intracranial pressure and reading the corre- 
sponding pressure changes with the measuring device; With the outputs properly connected to an oscilloscope and the phase shift control switch 168 in the open 
(“unlocked”) position, the received tonebursts and the phase 35 Of the cere- 
brospinal fluid while measuring the corresponding comparison voltages are displayed. The frequency of the 
changes in intracranial pressure with the calibrated synthesizer 100 is adjusted so that the amplitudes of the 
measuring device; reflected toneburst echoes at output 133 are far out of the 
noise, and the phase comparison output voltage at output (c) obtaining two sets of corresponding values for change 
143 is relatively “flat topped” and stable at that portion of the 40 in VOhme and change in intracranial Pressure; and 
tone burst echo chosen for measurement. The phase set point (d) obtaining values for the pressure volume index and the 
potentiometer 165 is adjusted until the phase comparison intracranial pressure for the patient based on the values 
voltage 180 corresponding to the desired tone burst is for change in volume and change in intracranial pres- 
approximately 0 V. The control point is adjusted so that the sure. 
phase signal is sampled well into its latter half. Because of 45 2. A method for non-invasive measurement of intracranial 
a time delay in the low-pass filter in the phase detector 140 pressure and pressure volume index according to claim 1, 
the phase signal is not precisely synchronized with the wherein said measuring device is an ultrasonic constant 
tonebursts. The phase shift control switch 168 is then placed frequency pulsed phase-locked-loop measuring device 
in its closed (“locked”) position for data taking. including an ultrasonic transducer applied to the skull of the 
A calibration procedure that uses a line stretcher 175 in 50 patient. 
the reference path (2) permits the conversion of the change 3. A method for non-invasive measurement of intracranial 
in control voltage, monitored by the voltmeter 200, to a pressure and pressure volume index according to claim 1, 
change in phase shift between the two paths. Calibration of wherein said known change in intracranial pressure is 
the voltage controlled phase shift network 170 in a CFPPLL induced by placing the patient on a tiltable bed and calcu- 
system is normally accomplished by adjusting the calibrated 55 lating said known change in intracranial pressure from the 
line stretcher 175 to introduce a known phase shift into the length of the patient’s cerebrospinal system and the tilt angle 
calibration path while the system is locked in data taking of the bed. 
mode. This results in a change in the phase shift control 4. A method for non-invasive measurement of intracranial 
voltage 180 to the voltage controlled phase shift network pressure and pressure volume index according to claim 1, 
170. The change in phase shift control voltage 180 is 60 wherein said known change in intracranial pressure is 
recorded, and a change of output voltage for a known phase induced by placing an inflatable cap on the patient’s skull 
shift is thus determined. This result is used to calculate and inflating said cap to a known pressure. 
changes to the measured phase shifts and, is particularly 5. A method for non-invasive measurement of intracranial 
important information to have in setups requiring measure- pressure and pressure volume index according to claim 1, 
ments of small phase shifts of a few hundred microradians. 65 wherein known changes in the volume of the cerebrospinal 
When the CFPPLL system is used for measuring and/or fluid are induced by injecting boluses of fluid into the spinal 
monitoring intracranial pressure ICP and pressure-volume cord of the patient. 
wave, are by this unit. Timing sequences are pressure and pressure volume index in a patient, comprising 
30 the steps of: 
(b) inducing known changes in the 
5,617,873 
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6.  A method for non-invasive measurement of intracranial 
pressure and pressure volume index according to claim 1, 
wherein known changes in the volume of the cerebrospinal 
fiuid are induced by temporary obstruction of veins or 
arteries in the patient’s neck while the blood flow into or out 5 
of the brain is measured. 
7. A method for non-invasive measurement of intracranial 
pressure and pressure volume index according to claim 1, 
wherein the step (d) comprises: 
(b) inducing a known change in intracranial pressure by 
placing the patient on a tiltable bed and calculating said 
known change in intracranial pressure from the length 
of the patient’s cerebrospinal system and the tilt angle 
of the bed; and 
(c) recording an output signal from said measuring device 
corresponding to said known change in intracranial 
pressure. 
9. A method for calibrating a device for monitoring 
changes in intracranial pressure in a patient comprising the 
steps of: 
(a) applying a measuring device to the patient to provide 
output signals in response to changes in intracranial 
pressure; 
(b) inducing a known change in intracranial pressure by 
placing an inflatable cap on the patient’s skull and 
(c) recording an output signal from said measuring device 
corresponding to said known change in intracranial 
pressure. 
obtaining values for the pressure volume index and the lo 
intracranial pressure for the patient based on the values 
for change in volume and change in intracranial pres- 
sure using the equation 
- AV 
AP=Po(lO PV’ - 1) 
15 
where AP is the change in intercranial pressure and Av is the 
change in volume obtained in step (c). 
changes in intracranial pressure in a patient comprising the 
steps of: 
(a) applying a measuring device to the patient to provide 
output signals in response to changes in intracranial 
pressure; * * * * *  
8, A method for calibrating a device for monitoring 20 inflating said to a known Pressure; and 
